Featured Research

from universities, journals, and other organizations

World First In Medical Robotics: Researchers Successfully Control Wireless Device Inside Artery

Date:
March 19, 2007
Source:
École Polytechnique de Montréal
Summary:
Some 40 years after the release of the classic science fiction movie Fantastic Voyage, researchers in the NanoRobotics Laboratory of École Polytechnique de Montréal's Department of Computer Engineering and Institute of Biomedical Engineering have achieved a major technological breakthrough in the field of medical robotics. They have succeeded for the first time in guiding, in vivo and via computer control, a microdevice inside an artery, at a speed of 10 centimetres a second.

Under the direction of Professor Sylvain Martel, holder of the Canada Research Chair in Micro/Nanosystem Development, Construction and Validation, and in collaboration with researchers at the Centre hospitalier de l'Université de Montréal (CHUM), the Polytechnique team has succeeded in injecting, propelling and controlling by means of software programs an initial prototype of an untethered device (a ferromagnetic 1.5- millimetre-diameter sphere) within the carotid artery of a living animal placed inside a clinical magnetic resonance imaging (MRI) system.
Credit: Image courtesy of École Polytechnique de Montréal

Some 40 years after the release of the classic science fiction movie Fantastic Voyage, researchers in the NanoRobotics Laboratory of École Polytechnique de Montréal's Department of Computer Engineering and Institute of Biomedical Engineering have achieved a major technological breakthrough in the field of medical robotics. They have succeeded for the first time in guiding, in vivo and via computer control, a microdevice inside an artery, at a speed of 10 centimetres a second.

Under the direction of Professor Sylvain Martel, holder of the Canada Research Chair in Micro/Nanosystem Development, Construction and Validation, and in collaboration with researchers at the Centre hospitalier de l'Université de Montréal (CHUM), the Polytechnique team has succeeded in injecting, propelling and controlling by means of software programs an initial prototype of an untethered device (a ferromagnetic 1.5- millimetre-diameter sphere) within the carotid artery of a living animal placed inside a clinical magnetic resonance imaging (MRI) system.

Encouraged by these results, staff at the Polytechnique NanoRobotics Laboratory are currently working to further reduce the size of the devices so that, within a few years, they can navigate inside smaller blood vessels.

"Injection and control of nanorobots inside the human body, which contains nearly 100,000 kilometres of blood vessels, is a promising avenue that could enable interventional medicine to target sites that so far have remained inaccessible using modern medical instruments such as catheters," Professor Martel explained. "In collaboration with our scientific partners, Polytechnique researchers have begun developing several types of micro- and nanodevices for novel applications, such as targeted delivery of medications to tumour sites and diagnoses using navigable bio-sensors."

The results of this scientific breakthrough were published by Professor Martel and 10 co-authors from École Polytechnique de Montréal and the CHUM on March 14 in the scientific journal Applied Physics Letters.

Patent applications have been submitted for this method of real-time monitoring and guidance of devices for minimally invasive surgeries using MRI. Commercialization of the technology has been entrusted to Gestion Univalor, LP.


Story Source:

The above story is based on materials provided by École Polytechnique de Montréal. Note: Materials may be edited for content and length.


Cite This Page:

École Polytechnique de Montréal. "World First In Medical Robotics: Researchers Successfully Control Wireless Device Inside Artery." ScienceDaily. ScienceDaily, 19 March 2007. <www.sciencedaily.com/releases/2007/03/070319113137.htm>.
École Polytechnique de Montréal. (2007, March 19). World First In Medical Robotics: Researchers Successfully Control Wireless Device Inside Artery. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2007/03/070319113137.htm
École Polytechnique de Montréal. "World First In Medical Robotics: Researchers Successfully Control Wireless Device Inside Artery." ScienceDaily. www.sciencedaily.com/releases/2007/03/070319113137.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins